Scientific Publications

Search by Keyword(s)
Found 15 results

Filters: Author is Hammerman, PS  [Clear All Filters]

Search Results

  • Showing 1-15 of 15 Results
2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.Seiwert, TY, Zuo Z., Keck MK, Khattri A., Pedamallu CS, Stricker TP, Brown CD, Pugh TJ, Stojanov P., Cho J., Lawrence M., Getz G., Bragelmann J., DeBoer R., Weichselbaum RR, Langerman A., Portugal LD, Blair EA, Stenson KM, Lingen MW, et al. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014/07/23, (2014) Read More / View Supplemental Materials
Abstract
Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a pan-FGFR inhibitor in a mouse model of NSCLC.Wong, KK, Tchaicha JH, Akbay EA, Altabef A., Mikse OR, Kikuchi E., Rhee K., Liao RG, Bronson RT, Sholl LM, Meyerson M., and Hammerman PS Cancer research, 2014/07/17, (2014) Read More / View Supplemental Materials
Abstract
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.Wilkerson, MD, Cabanski CR, Sun W., Hoadley KA, Walter V., Mose LE, Troester MA, Hammerman PS, Parker JS, Perou CM, and Hayes DN Nucleic acids research, 2014/06/26, (2014) Read More / View Supplemental Materials
Abstract
Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells.Wang, J., Mikse O., Liao RG, Li Y., Tan L., Janne PA, Gray NS, Wong KK, and Hammerman PS Oncogene, 2014/06/09, (2014) Read More / View Supplemental Materials
Abstract
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression.Xu, C., Fillmore CM, Koyama S., Wu H., Zhao Y., Chen Z., Herter-Sprie GS, Akbay EA, Tchaicha JH, Altabef A., Reibel JB, Walton Z., Ji H., Watanabe H., Jänne PA, Castrillon DH, Rustgi AK, Bass AJ, Freeman GJ, Padera RF, et al. Cancer cell, 2014/05/12, Volume 25, Issue 5, p.590-604, (2014) Read More / View Supplemental Materials
Abstract
2013
Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients.Kim, Y., Hammerman PS, Kim J., Yoon JA, Lee Y., Sun JM, Wilkerson MD, Pedamallu CS, Cibulskis K., Yoo YK, Lawrence MS, Stojanov P., Carter SL, McKenna A., Stewart C., Sivachenko AY, Oh IJ, Kim HK, Choi YS, Kim K., et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013/12/09, (2013) Read More / View Supplemental Materials
Abstract
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.Vaishnavi, A., Capelletti M., Le AT, Kako S., Butaney M., Ercan D., Mahale S., Davies KD, Aisner DL, Pilling AB, Berge EM, Kim J., Sasaki H., Park SI, Kryukov G., Garraway LA, Hammerman PS, Haas J., Andrews SW, Lipson D., et al. Nature medicine, 2013/10/27, (2013) Read More / View Supplemental Materials
Abstract
Integrative radiogenomic profiling of squamous cell lung cancer.Abazeed, ME, Adams DJ, Hurov KE, Tamayo P., Creighton CJ, Sonkin D., Giacomelli AO, Du C., Fries DF, Wong KK, Mesirov J. P., Loeffler JS, Schreiber SL, Hammerman PS, and Meyerson M. Cancer research, 2013/10/15, Volume 73, Issue 20, p.6289-98, (2013) Read More / View Supplemental Materials
Abstract
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.Akbay, EA, Koyama S., Carretero J., Altabef A., Tchaicha JH, Christensen CL, Mikse OR, Cherniack AD, Beauchamp EM, Pugh TJ, Wilkerson MD, Fecci PE, Butaney M., Reibel JB, Soucheray M., Cohoon TJ, Janne PA, Meyerson M., Hayes DN, Shapiro GI, et al. Cancer discovery, 2013/09/27, (2013) Read More / View Supplemental Materials
Abstract
Mutational heterogeneity in cancer and the search for new cancer-associated genes.Lawrence, MS, Stojanov P., Polak P., Kryukov GV, Cibulskis K., Sivachenko A., Carter SL, Stewart C., Mermel CH, Roberts SA, Kiezun A., Hammerman PS, McKenna A., Drier Y., Zou L., Ramos AH, Pugh TJ, Stransky N., Helman E., Kim J., et al. Nature, 2013/07/11, Volume 499, Issue 7457, p.214-8, (2013) Read More / View Supplemental Materials
Abstract
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Liao, RG, Jung J., Tchaicha JH, Wilkerson MD, Sivachenko A., Beauchamp EM, Pugh TJ, Pedamallu CS, Hayes DN, Gray NS, Getz G., Wong KK, Meyerson M., and Hammerman PS Cancer research, 2013/06/20, (2013) Read More / View Supplemental Materials
Abstract
2012
Targeted therapy for squamous cell lung cancer.Liao, RG, Watanabe H., Meyerson M., and Hammerman PS Lung cancer management, 2012/12/01, Volume 1, Issue 4, p.293-300, (2012) Read More / View Supplemental Materials
Abstract
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.Imielinski, M., Berger AH, Hammerman PS, Hernandez B., Pugh TJ, Hodis E., Cho J., Sivachenko A., Sougnez C., Auclair D., Lawrence MS, Stojanov P., Cibulskis K., Sharifnia T., Greulich H., Banerji S., Zander T., Thompson K., Winckler W., Kwiatkowski D., et al. Cell, 2012/09/14, Volume 150, Issue 6, p.1107-20, (2012) Read More / View Supplemental Materials
Abstract
Comprehensive genomic characterization of squamous cell lung cancers.The Cancer Genome Atlas Research, Network, institution.)(Participants are arranged by area of contribution and then by, Genome sequencing centres: Broad Institute, Hammerman PS, Lawrence MS, Voet D., Jing R., Cibulskis K., Sivachenko A., Stojanov P., McKenna A., Lander E. S., Gabriel S., Getz G., Sougnez C., Imielinski M., Helman E., Hernandez B., Pho NH, Meyerson M., et al. Nature, 2012/09/09, (2012) Read More / View Supplemental Materials
Abstract
2011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.Dutt, A., Ramos AH, Hammerman PS, Mermel C., Cho J., Sharifnia T., Chande A., Tanaka KE, Stransky N., Greulich H., Gray NS, and Meyerson M. PloS one, 2011/01/01, Volume 6, Issue 6, p.e20351, (2011) Read More / View Supplemental Materials
Abstract
  • Showing 1-15 of 15 Results